-
公开(公告)号:EP1594861A1
公开(公告)日:2005-11-16
申请号:EP04708353.0
申请日:2004-02-05
申请人: Abbott GmbH & Co. KG
发明人: STARCK, Dorothea , TREIBER, Hans-Jörg , ZIERKE, Thomas , KETTSCHAU, Georg , GENESTE, Hervé , HAUPT, Andreas , UNGER, Liliane , BLUMBACH, Kai , SCHÖBEL, Dietmar , TESCHENDORF, Hans-Jürgen
IPC分类号: C07D403/12 , C07D401/12 , A61K31/41 , A61P25/00
CPC分类号: C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D417/14
摘要: The invention relates to triazole compounds of general formula (I), wherein A, B, R1, R2, R3 and R4 have the meaning cited in claim 1. The invention also relates to a pharmaceutical agent containing at least one compound of general formula (I) in addition to the use of the compound (I) for producing a pharmaceutical agent for treating illnesses, responding to the effects of dopamine-D3-receptor antagonists or dopamine-D3-receptor agonists, especially for treating disorders in the central nervous system.
-
公开(公告)号:EP0956294B1
公开(公告)日:2004-06-09
申请号:EP97936672.1
申请日:1997-07-29
申请人: Abbott GmbH & Co. KG
发明人: BAUCKE, Dorit , LANGE, Udo , MACK, Helmut , SEITZ, Werner , ZIERKE, Thomas , HÖFFKEN, Hans, Wolfgang , HORNBERGER, Wilfried
CPC分类号: C07K5/06078 , A61K38/00
-
-
公开(公告)号:EP1594861B1
公开(公告)日:2008-06-18
申请号:EP04708353.0
申请日:2004-02-05
申请人: Abbott GmbH & Co. KG
发明人: STARCK, Dorothea , TREIBER, Hans-Jörg , ZIERKE, Thomas , KETTSCHAU, Georg , GENESTE, Hervé , HAUPT, Andreas , UNGER, Liliane , BLUMBACH, Kai , SCHÖBEL, Dietmar , TESCHENDORF, Hans-Jürgen
IPC分类号: C07D403/12 , C07D401/12 , A61K31/41 , A61P25/00
CPC分类号: C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D417/14
摘要: The invention relates to triazole compounds of general formula (I), wherein A, B, R1, R2, R3 and R4 have the meaning cited in claim 1. The invention also relates to a pharmaceutical agent containing at least one compound of general formula (I) in addition to the use of the compound (I) for producing a pharmaceutical agent for treating illnesses, responding to the effects of dopamine-D3-receptor antagonists or dopamine-D3-receptor agonists, especially for treating disorders in the central nervous system.
-
公开(公告)号:EP0915844B1
公开(公告)日:2006-04-26
申请号:EP97933675.7
申请日:1997-07-14
申请人: Abbott GmbH & Co. KG
发明人: MACK, Helmut , PFEIFFER, Thomas , SEITZ, Werner , ZIERKE, Thomas , BALKENHOHL, Friedhelm , LANGE, Udo
IPC分类号: C07D207/22 , C12P17/10
CPC分类号: C07D207/22
摘要: A process is disclosed for preparing 3-pyrroline-2-carboxylic acid derivatives of formula (I), in which R1 stands for H, C¿1?-C6-alkyl, benzyl, benzyl substituted at the phenyl radical, allyloxycarbonyl, C1-C6-alkyloxycarbonyl, benzyloxycarbonyl, in which the benzyl radical can be substituted by OCH3 radicals, or for C1-C4-alkylcarbonyl; or R?1¿ stands for an amino acid radical which can be alkylated or acylated at the nitrogen and is linked by the C-terminal; and R2 stands for OH, C¿1?-C4-alkyloxy, benzyloxy or an N?3R4¿ group, in which R?3 and R4¿ represent independently from each other H, C¿1?-C4-alkyl, benzyl, phenyl or pyridyl, in which the aromatic compounds in R?3 and R4¿ can be substituted by up to three identical or different substituents selected from the group composed of methyl, methoxy, hydroxy, cyano or halogen. According to this process, the sulphonic acid radical is eliminated by means of a base from a compound having the formula (II), in which R?1 and R2¿ have the above meanings and R5 stands for C¿1?-C6-alkyl, benzyl, trifluoromethyl, naphthyl or phenyl optionally substituted by radicals from the group composed of methyl, nitro and halogen.
-
公开(公告)号:EP0866800B1
公开(公告)日:2004-09-22
申请号:EP96943076.8
申请日:1996-12-11
申请人: Abbott GmbH & Co. KG
发明人: AMBERG, Wilhelm , BARLOZZARI, Teresa , BERNARD, Harald , BUSCHMANN, Ernst , HAUPT, Andreas , HEGE, Hans-Guenther , JANSSEN, Bernd , KLING, Andreas , LIETZ, Helmut , RITTER, Kurt , ULLRICH, Martina , WEYMANN, Jürgen , ZIERKE, Thomas
CPC分类号: A61K38/08
-
-
-
-
-